<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01545505</url>
  </required_header>
  <id_info>
    <org_study_id>11-AOI-09</org_study_id>
    <nct_id>NCT01545505</nct_id>
  </id_info>
  <brief_title>Identification of Markers of Post-Traumatic Stress Disorder (PTSD) Relapse</brief_title>
  <official_title>Early Diagnosis of Risk of Post-Traumatic Stress Disorder (PTSD) Relapse in Children and Their Families</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Relapse of post-traumatic stress disorder (PTSD) remains challenging. In addition, factors&#xD;
      predicting PTSD relapse are still unknown. The aim of this study is to examine whether&#xD;
      clinical and neuropsychological changes (e.g., attentional bias toward aversive cues) that&#xD;
      characterized PTSD can be observed in people with past PTSD (children and their families) and&#xD;
      whether these persistent changes are predictive of PTSD relapse.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the great challenges in Psychotraumatology is the high risk (20-40%) of post-traumatic&#xD;
      stress disorder (PTSD) relapse, which markers remain understudied. Identification of these&#xD;
      markers is of particular interest for the development of strategies to prevent relapse. Based&#xD;
      on clinical and experimental data, it appears that (i) the so-called residual clinical&#xD;
      symptoms (such as sleep disturbance, irritability) and (ii) the neuropsychological&#xD;
      dysfunctions (cognitive difficulties), persisting after remission, may constitute markers of&#xD;
      PTSD relapse. Moreover, all of these potential markers have also been linked with&#xD;
      dysfunctions, persisting or reoccurring, in the prefrontal cortex after remission.&#xD;
&#xD;
      The main objective of this study is to identify these clinical and neuropsychological markers&#xD;
      of PTSD relapse in children and their families. The secondary objective is to demonstrate the&#xD;
      link between prefrontal dysfunctions and relapse.&#xD;
&#xD;
      This longitudinal study will include 4 experimental groups:&#xD;
&#xD;
        -  30 children with PTSD&#xD;
&#xD;
        -  30 children with past PTSD (children in remission)&#xD;
&#xD;
        -  30 parents of children with PTSD&#xD;
&#xD;
        -  30 parents of children with past PTSD The first visit is planned during the symptomatic&#xD;
           phase (T0). The second visit (T1) is planned at the end of the symptomatic phase (or 6&#xD;
           months later T0). The last visit is planned 3-months after T1.&#xD;
&#xD;
      The psychological assessment will include:&#xD;
&#xD;
      A structured interview with a psychiatrist An assessment of PTSD symptoms (IES-R, CPTS-RI for&#xD;
      children) An assessment of the co-morbidity (STAI C and CDI for children, STAI A-B, BDI for&#xD;
      adults).&#xD;
&#xD;
      An evaluation of the social life (EAS for children and SAS-SR for adults).&#xD;
&#xD;
      The neuropsychological assessment will include:&#xD;
&#xD;
      An evaluation of the attentional treatment (Go-No / go and visual search) An evaluation of&#xD;
      executive functions (TMT A and B) A brief evaluation of the IQ (items memory of figures,&#xD;
      matrix and resemblance) An evaluation of the memory (Grober and Buschke) Tests include an&#xD;
      adult and children versions that are validated. All studies will be conducted at the Nice&#xD;
      University Hospital, Tours University Hospital and Toulouse University Hospital.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Attentional score</measure>
    <time_frame>baseline at the first visit (T0), at 6 months, at 9 months</time_frame>
    <description>Go-No/Go and visual search tests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>memory (Grober and Buschke)</measure>
    <time_frame>baseline at the first visit (T0), at 6 months, at 9 months</time_frame>
    <description>Grober and Buschke memory tests</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Post Traumatic Stress Disorder (PTSD)</condition>
  <arm_group>
    <arm_group_label>In remission phase of PTSD</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients having suffered from PTSD in the past and in remission od PTSD and their parents</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Activ PTSD</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients suffering from PTSD (Post-traumatic Stress Disorder) and their parents</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neuropsychological assessment</intervention_name>
    <description>A clinical evaluation with Impact of Events Scale-Revised, Child Post-Traumatic Stress Reaction Index, State-Trait Anxiety Inventory for Children, Children Depression Inventory and Emotion, activity and sociability.&#xD;
A neuropsychological assessment with a emotional Go-No/Go, a visual search task, the Trail Making Test, 3 items of the WISC III ( and the Grober and Buschke Test.</description>
    <arm_group_label>Activ PTSD</arm_group_label>
    <arm_group_label>In remission phase of PTSD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For children&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Children (9/18 years)&#xD;
&#xD;
          -  Patients who have lived a traumatic event (physical assault and road accident) and who&#xD;
             have a PTSD.&#xD;
&#xD;
          -  French speaker.&#xD;
&#xD;
          -  Participants must sign the informed consent and they must be affiliated to the social&#xD;
             insurance.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Children who have a neurological pathology.&#xD;
&#xD;
          -  Children who have brain damage or brain-injured&#xD;
&#xD;
          -  Subject having participated in a biomedical research in three months preceding the&#xD;
             inclusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel BENOIT, M.D.,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Psychiatrie, Hôpital Pasteur, CHU de NICE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wissam EL HAGE, M.D, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Psychiatrie, CHU de TOURS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frédérique JOVER, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>CAP, Hôpital St ROCH, CHU de NICE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Florence ASKENAZY, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation Lenval, NICE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe BIRMES, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Psychiatrie, CHU de TOULOUSE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Virginie BUISSE, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>CAP, Hôpital St Roch, CHU de NICE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michel BENOIT, PhD</last_name>
    <email>benoit.m@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>morgane gindt</last_name>
    <email>morganegindt@yahoo.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de NICE</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel BENOIT, M.D., PhD</last_name>
      <email>benoit.m@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Michel BENOIT, M.D., PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédérique JOVER, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie BUISSE, M.D, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondation Lenval</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>florence Askenazy, M.D.</last_name>
      <email>florence.askenazy@lenval.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de TOULOUSE</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Philippe BIRMES, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de TOURS</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Wissam EL HAGE, M.D., PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <study_first_submitted>December 8, 2011</study_first_submitted>
  <study_first_submitted_qc>March 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2012</study_first_posted>
  <last_update_submitted>February 20, 2013</last_update_submitted>
  <last_update_submitted_qc>February 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

